APA-referens

Makita, S., Maruyama, D., & Tobinai, K. (2020). Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma. Onco Targets Ther.

Chicago-stil citat

Makita, Shinichi, Dai Maruyama, och Kensei Tobinai. "Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma." Onco Targets Ther 2020.

MLA-referens

Makita, Shinichi, Dai Maruyama, och Kensei Tobinai. "Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma." Onco Targets Ther 2020.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.